Cargando…
L-Carnitine and Acetyl-L-Carnitine: Potential Novel Biomarkers for Major Depressive Disorder
The lack of biomarkers greatly limits the diagnosis and treatment of major depressive disorder (MDD). Endogenous L-carnitine (LC) and its derivative acetyl-L-carnitine (ALC) play antidepressant roles by improving brain energy metabolism, regulating neurotransmitters and neural plasticity. The levels...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514700/ https://www.ncbi.nlm.nih.gov/pubmed/34658942 http://dx.doi.org/10.3389/fpsyt.2021.671151 |
_version_ | 1784583450050691072 |
---|---|
author | Nie, Li-Juan Liang, Jun Shan, Feng Wang, Bao-Shi Mu, Yuan-Yuan Zhou, Xie-Hai Xia, Qing-Rong |
author_facet | Nie, Li-Juan Liang, Jun Shan, Feng Wang, Bao-Shi Mu, Yuan-Yuan Zhou, Xie-Hai Xia, Qing-Rong |
author_sort | Nie, Li-Juan |
collection | PubMed |
description | The lack of biomarkers greatly limits the diagnosis and treatment of major depressive disorder (MDD). Endogenous L-carnitine (LC) and its derivative acetyl-L-carnitine (ALC) play antidepressant roles by improving brain energy metabolism, regulating neurotransmitters and neural plasticity. The levels of ALC in people and rodents with depression are significantly reduced. It is necessary to determine whether serum LC and ALC might be used as novel biomarkers for the diagnosis of MDD. Here, ultra-high performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) was used to determine the concentration of LC and ALC in the serum of healthy controls and patients with MDD; among the latter, in patients who were responsive (effective group) and non-responsive (ineffective group) after 2 weeks of treatment. The diagnostic value of serum LC and ALC for MDD was assessed. Compared with healthy controls, the serum LC and ALC concentrations in patients with MDD were significantly decreased (P < 0.001). Pearson correlation analysis shows that the HDRS-24 score was negatively associated with serum ALC (r = −0.325, P = 0.007). Receiver operating characteristic (ROC) analysis revealed an area under the curve (AUC) of 0.801 with 83.1% sensitivity and 66.3% specificity for LC, and an AUC of 0.898 with 88.8% sensitivity and 76.4% specificity for ALC, differentiating patients with MDD from healthy controls. Furthermore, the concentration of LC and ALC in patients with depression was significantly increased in the effective treatment group, and no significant change was observed in the ineffective treatment group. These results suggest that serum LC and ALC may be novel biomarkers for the diagnosis of MDD. |
format | Online Article Text |
id | pubmed-8514700 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85147002021-10-15 L-Carnitine and Acetyl-L-Carnitine: Potential Novel Biomarkers for Major Depressive Disorder Nie, Li-Juan Liang, Jun Shan, Feng Wang, Bao-Shi Mu, Yuan-Yuan Zhou, Xie-Hai Xia, Qing-Rong Front Psychiatry Psychiatry The lack of biomarkers greatly limits the diagnosis and treatment of major depressive disorder (MDD). Endogenous L-carnitine (LC) and its derivative acetyl-L-carnitine (ALC) play antidepressant roles by improving brain energy metabolism, regulating neurotransmitters and neural plasticity. The levels of ALC in people and rodents with depression are significantly reduced. It is necessary to determine whether serum LC and ALC might be used as novel biomarkers for the diagnosis of MDD. Here, ultra-high performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) was used to determine the concentration of LC and ALC in the serum of healthy controls and patients with MDD; among the latter, in patients who were responsive (effective group) and non-responsive (ineffective group) after 2 weeks of treatment. The diagnostic value of serum LC and ALC for MDD was assessed. Compared with healthy controls, the serum LC and ALC concentrations in patients with MDD were significantly decreased (P < 0.001). Pearson correlation analysis shows that the HDRS-24 score was negatively associated with serum ALC (r = −0.325, P = 0.007). Receiver operating characteristic (ROC) analysis revealed an area under the curve (AUC) of 0.801 with 83.1% sensitivity and 66.3% specificity for LC, and an AUC of 0.898 with 88.8% sensitivity and 76.4% specificity for ALC, differentiating patients with MDD from healthy controls. Furthermore, the concentration of LC and ALC in patients with depression was significantly increased in the effective treatment group, and no significant change was observed in the ineffective treatment group. These results suggest that serum LC and ALC may be novel biomarkers for the diagnosis of MDD. Frontiers Media S.A. 2021-09-30 /pmc/articles/PMC8514700/ /pubmed/34658942 http://dx.doi.org/10.3389/fpsyt.2021.671151 Text en Copyright © 2021 Nie, Liang, Shan, Wang, Mu, Zhou and Xia. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Psychiatry Nie, Li-Juan Liang, Jun Shan, Feng Wang, Bao-Shi Mu, Yuan-Yuan Zhou, Xie-Hai Xia, Qing-Rong L-Carnitine and Acetyl-L-Carnitine: Potential Novel Biomarkers for Major Depressive Disorder |
title | L-Carnitine and Acetyl-L-Carnitine: Potential Novel Biomarkers for Major Depressive Disorder |
title_full | L-Carnitine and Acetyl-L-Carnitine: Potential Novel Biomarkers for Major Depressive Disorder |
title_fullStr | L-Carnitine and Acetyl-L-Carnitine: Potential Novel Biomarkers for Major Depressive Disorder |
title_full_unstemmed | L-Carnitine and Acetyl-L-Carnitine: Potential Novel Biomarkers for Major Depressive Disorder |
title_short | L-Carnitine and Acetyl-L-Carnitine: Potential Novel Biomarkers for Major Depressive Disorder |
title_sort | l-carnitine and acetyl-l-carnitine: potential novel biomarkers for major depressive disorder |
topic | Psychiatry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514700/ https://www.ncbi.nlm.nih.gov/pubmed/34658942 http://dx.doi.org/10.3389/fpsyt.2021.671151 |
work_keys_str_mv | AT nielijuan lcarnitineandacetyllcarnitinepotentialnovelbiomarkersformajordepressivedisorder AT liangjun lcarnitineandacetyllcarnitinepotentialnovelbiomarkersformajordepressivedisorder AT shanfeng lcarnitineandacetyllcarnitinepotentialnovelbiomarkersformajordepressivedisorder AT wangbaoshi lcarnitineandacetyllcarnitinepotentialnovelbiomarkersformajordepressivedisorder AT muyuanyuan lcarnitineandacetyllcarnitinepotentialnovelbiomarkersformajordepressivedisorder AT zhouxiehai lcarnitineandacetyllcarnitinepotentialnovelbiomarkersformajordepressivedisorder AT xiaqingrong lcarnitineandacetyllcarnitinepotentialnovelbiomarkersformajordepressivedisorder |